Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03198143
Other study ID # Pro00077515
Secondary ID
Status Withdrawn
Phase Phase 1
First received
Last updated
Start date October 2019
Est. completion date February 2022

Study information

Verified date January 2020
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effect of the "hunger hormone" ghrelin on human decision-making. Participants will be given an injection of ghrelin or saline on different study days and will then be asked to make a series of computer-based decisions. The investigators hypothesize that ghrelin will increase participant's preference for energy-dense foods and will also increase impulsiveness in decision making.


Description:

Ghrelin is a hormone made by the stomach that stimulates hunger and feeding behavior. How ghrelin affects human decision-making is poorly understood. This study will investigate the effect of ghrelin on nutrition-related and time-based decisions in humans. Participants eye movements will be tracked by a computer during the decision-making process.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date February 2022
Est. primary completion date February 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Ability to speak and understand English

- BMI of 18.0 - 24.9 kg/m2 or 30.0 - 50.0 kg/m2

Exclusion Criteria:

- Diagnosis of diabetes mellitus (including gestational diabetes)

- Active infections

- History of malignant or inflammatory conditions, such as rheumatoid arthritis and inflammatory bowel disease

- History of myocardial infarction or congestive heart failure

- Active liver or kidney disease

- Uncontrolled hypertension

- Pituitary or adrenal disorders or neuroendocrine tumors

- History of anorexia nervosa, bulimia, or eating disorders not otherwise specified (NOS); Score of "at risk" on the EAT-26 eating disorder screening tool

- Diagnosis of attention-deficient/hyperactivity disorder (ADHD)

- Malabsorptive gastrointestinal disease, gastroparesis, or history of gastrointestinal surgery

- Pregnancy or lactation

- Requirement of daily medications that alter gastrointestinal function (including, but not limited to, glucocorticoids, psychotropics, narcotics, and metoclopramide).

- Requirement of glasses for impaired vision (including reading glasses). Subjects who wear contact lenses for vision correction will not be excluded.

- Insufficient visual acuity to read and interpret the decision stimuli

- Insufficient motor capabilities to press a button, move the joystick, or move their eyes to indicate a response

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ghrelin
Subjects will receive a subcutaneous injection of synthetic acyl ghrelin (12 µg/kg) at the start of the study.
Saline
Subjects will receive a subcutaneous injection of saline (0.9%) at the start of the study.

Locations

Country Name City State
United States Duke Sociology-Psychology Building 417 Chapel Drive Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Jenny Tong, MD, MPH

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of Ghrelin on food choices in Task 1. The difference in the proportion of healthy and unhealthy choices in the Saline and Ghrelin conditions. Approximately 25 minutes
Primary Effect of Ghrelin on temporal choices in Task 2 The difference in the proportion of smaller sooner and larger later choices in the Saline and Ghrelin conditions Approximately 25 minutes
Secondary Dwell time on each choice during Task 1 For eye-tracking, total dwell time (in ms) on each item in a food choice will be compared in both experimental conditions. Approximately 25 minutes
Secondary Number of fixations on foods during Task 1 The total number of fixations on each food option will be compared in both experimental conditions. Approximately 25 minutes
Secondary Dwell time on each choice during Task 2 For eye-tracking, total dwell time (in ms) on each item in the monetary choice will be compared in both experimental conditions. Approximately 25 minutes
Secondary Number of fixations on foods during Task 2 The total number of fixations on each monetary option will be compared in both experimental conditions. Approximately 25 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2